Characterization of anti-fentanyl antibodies as antagonists of ultra-toxic, clinically relevant or endogenous opioids. 

Characterization of anti-fentanyl antibodies as antagonists of ultra-toxic, clinically relevant or endogenous opioids. 

Endt F, Steinritz D, Amend N, Gudermann T, Breit A. 

Arch Toxicol. 2026 Jun;100(6):2503-2515. doi: 10.1007/s00204-026-04331-0. Epub 2026 Mar 10. PMID: 41807788; PMCID: PMC13221331.

https://pmc.ncbi.nlm.nih.gov/articles/PMC13221331/